Home / MGMT Knockout Cell Lines

MGMT Knockout Cell Lines

Gene: MGMT

Official Full Name: O-6-methylguanine-DNA methyltransferaseprovided by HGNC

Gene Summary: Alkylating agents are potent carcinogens that can result in cell death, mutation and cancer. The protein encoded by this gene is a DNA repair protein that is involved in cellular defense against mutagenesis and toxicity from alkylating agents. The protein catalyzes transfer of methyl groups from O(6)-alkylguanine and other methylated moieties of the DNA to its own molecule, which repairs the toxic lesions. Methylation of the genes promoter has been associated with several cancer types, including colorectal cancer, lung cancer, lymphoma and glioblastoma. [provided by RefSeq, Sep 2015]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO00109 MGMT Knockout cell line (HeLa) Human MGMT 1:3~1:6 Negative Online Inquiry
KO03884 MGMT Knockout cell line (HCT 116) Human MGMT 1:2~1:4 Negative Online Inquiry
KO03885 MGMT Knockout cell line (HEK293) Human MGMT 1:3~1:6 Negative Online Inquiry
KO03886 MGMT Knockout cell line (A549) Human MGMT 1:3~1:4 Negative Online Inquiry

Background

MGMT Gene Knockout Cell Lines are meticulously engineered cellular models designed to disable the O6-methylguanine-DNA methyltransferase (MGMT) gene, crucial for DNA repair mechanisms. This gene plays a vital role in counteracting the effects of alkylating agents, making its knockout significant for various research applications. By inhibiting MGMT, these knockout cell lines present a unique opportunity for scientists to study the impacts of modulating DNA repair pathways and explore tumorigenesis in greater depth.

The primary function of these cell lines is to facilitate the investigation of chemotherapeutic responses and understand the underlying mechanisms of drug resistance, particularly in cancers with high mutation burdens or those that utilize DNA alkylating agents in treatment protocols. By eliminating MGMT activity, researchers can probe cellular responses to DNA damage, evaluate the efficacy of novel compounds, and identify potential biomarkers for sensitivity or resistance to therapy.

The scientific importance of MGMT Gene Knockout Cell Lines extends into both preclinical and clinical research settings. They are crucial for screening new anticancer drugs, understanding cancer biology, and developing therapeutic strategies that can overcome resistance mechanisms. The ability to create tailored models that replicate human pathophysiology significantly enhances the translation of findings from bench to bedside.

In comparison to traditional cell lines, MGMT knockout models offer distinct advantages. Their precise genetic modification provides a more relevant context for studying the therapeutic efficacy of drugs in DNA repair-deficient environments. This specificity reduces the variability associated with conventional cell lines, thereby enhancing data reproducibility and credibility in research findings.

Ultimately, MGMT Gene Knockout Cell Lines represent an invaluable tool for researchers and clinicians aiming to advance precision medicine and cancer therapies. These cell lines not only aid in elucidating complex biological processes but also facilitate breakthrough discoveries that could lead to improved treatment outcomes for patients. As a company dedicated to delivering high-quality biological products, we pride ourselves on our expertise and commitment to empowering researchers with tools that drive innovation and accelerate scientific progress.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.